Joseph P. Hagan - Chief Executive Officer, Director at Regulus Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
RGLS on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Joseph P. Hagan - trading volume in the past year for Regulus Therapeutics Inc.

Holdings reported by Joseph P. Hagan for Regulus Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 261K $283K $1.09 Jan 30, 2025 Direct
Stock Option (Right to Buy) 1.35M Jan 30, 2025 Direct Common Stock

Transactions reported by Joseph P. Hagan for Regulus Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.